We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+12.36%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.45B
AUM Growth
+$91.7M
(+6.7%)
Cap. Flow
-$34M
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
38.91%
Holding
217
New
7
Increased
36
Reduced
127
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$2.91M |
| 2 |
Medtronic
MDT
|
+$2.84M |
| 3 |
Perrigo
PRGO
|
+$2.61M |
| 4 |
Teradyne
TER
|
+$1.71M |
| 5 |
TJX Companies
TJX
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.9M |
| 2 |
NVIDIA
NVDA
|
+$3.71M |
| 3 |
Amalgamated Financial
AMAL
|
+$2.86M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.78M |
| 5 |
Analog Devices
ADI
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.94% |
| 2 | Healthcare | 25.6% |
| 3 | Industrials | 15.08% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 9.21% |
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Reynders McVeigh Capital Management held 217 positions worth $1.45B, up 6.7% from $1.36B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Reynders McVeigh Capital Management's Q1 2023 filing shows 7 new, 36 increased, 127 reduced and 14 closed positions. Its largest new stake was Perrigo: 72,303 shares worth $2.59M. The largest sale was Apple, an estimated $3.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- Reynders McVeigh Capital Management's largest Q1 2023 buy was Perrigo: 72,303 shares worth $2.59M.
- Reynders McVeigh Capital Management added most to Aptiv in Q1 2023, an estimated $2.91M increase.
- Reynders McVeigh Capital Management's biggest Q1 2023 reduction was Apple, cutting an estimated $3.9M.
- Reynders McVeigh Capital Management fully exited AstraZeneca in Q1 2023, selling an estimated $651K.
- Reynders McVeigh Capital Management's ten largest holdings make up 39% of its $1.45B portfolio in Q1 2023.
- Reynders McVeigh Capital Management opened 7 new positions and closed 14 in Q1 2023.
- Reynders McVeigh Capital Management's portfolio value rose 6.7% quarter-over-quarter to $1.45B.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2023, filed 3 May 2023.